Product Information

LEVETIRACETAM 1,000 MG TABLET is a generic product labeled by Cranbury Pharmaceuticals, LLC, priced at $0.1645 per EA under NDC 27808026601. Its NADAC has been published 170 times since Aug 16, 2023.

FDA first approved this application on Dec 14, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVETIRACETAM 1,000 MG TABLET

Levetiracetam
$0.1645per EA

Strength

1000 mg/1

NDC

27808026601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

LEVETIRACETAM

Approval Type

Generic (ANDA)

FDA Application

ANDA091491

FDA Approved

12/14/2010

TE Code

AB

On Market Since

5/1/2023

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for LEVETIRACETAM 1,000 MG TABLET has been published 170 times since Aug 16, 2023, and over the history we have for it it has declined 19.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1645 per EA
All-time high$0.2036 (Aug 16, 2023)
All-time low$0.1447 (Nov 20, 2024)
52-week high$0.1663
52-week low$0.1552
Median price$0.1643
Average price$0.1707
Largest weekly change+17.3% (Aug 21, 2024)
Weeks tracked170
Tracking sinceAug 16, 2023

Price History

1W

0.0%

1M

+3.0%

3M

+6.0%

6M

+0.1%

1Y

+1.7%

3Y

-18.3%

5Y

N/A

All

-19.2%

Generic Alternatives

The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LEVETIRACETAM 1,000 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 1,000 MG TABLET, manufactured by Cranbury Pharmaceuticals, LLC, is $0.1645 per EA (NDC 27808026601), effective Nov 11, 2026.

How has the price of LEVETIRACETAM 1,000 MG TABLET changed over time?

Over the history we have for it, the NADAC for LEVETIRACETAM 1,000 MG TABLET has declined 19.2%. It has been tracked across 170 weekly CMS publications since Aug 16, 2023.

What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 1,000 MG TABLET?

Since Aug 16, 2023, the NADAC for LEVETIRACETAM 1,000 MG TABLET has ranged from a low of $0.1447 (Nov 20, 2024) to a high of $0.2036 (Aug 16, 2023), with a median of $0.1643 per EA.

Are there cheaper alternatives to LEVETIRACETAM 1,000 MG TABLET?

Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 1,000 MG TABLET, is $0.1624 per EA — about 1% below LEVETIRACETAM 1,000 MG TABLET.

Who manufactures LEVETIRACETAM 1,000 MG TABLET?

LEVETIRACETAM 1,000 MG TABLET (NDC 27808026601) is labeled by Cranbury Pharmaceuticals, LLC, and CMS classifies it as a generic product.